Similar studies found that anti-C1s antibodies were effective in blocking complement activation induced by auto-antibodies from patients with several types of autoimmune hemolytic anemia, such as paroxysmal nocturnal hemoglobinuria and CAD (14). Here, C1S is linked to cold agglutinin disease.